PAM50 is a generic oncogene panel for breast cancer that measures the expression level of 50 cancer-related genes as a package using microarrays, etc., and classifies them according to their gene expression characteristics (gene signature) into five subtypes (luminal A, luminal B, HER2 enriched, basal-like, and normal-like). This evidence concerns the gene ERBB2 and breast carcinoma.